Literature DB >> 31279635

Multimodal neuroimaging relationships in progressive supranuclear palsy.

Irene Sintini1, Christopher G Schwarz2, Matthew L Senjem3, Robert I Reid4, Hugo Botha5, Farwa Ali5, J Eric Ahlskog5, Clifford R Jack2, Val J Lowe2, Keith A Josephs5, Jennifer L Whitwell2.   

Abstract

Progressive supranuclear palsy is characterized primarily by 4R tau inclusions, atrophy in the brainstem and basal ganglia, and neurodegeneration along the dentatorubrothalamic tract, which are measurable in vivo using flortaucipir PET, T1-weighted MRI, and MRI with diffusion tensor imaging (DTI). However, little is known about how these processes relate to each other. The aim of this study was to investigate multimodal associations between flortaucipir PET uptake, tissue volume loss on structural MRI and white matter tract disruption on DTI. Thirty-four patients with progressive supranuclear palsy and 29 normal controls underwent flortaucipir PET, MRI and DTI. Voxel-wise comparison was performed between patients and controls. Sparse canonical correlations analysis was applied on regional measurements of flortaucipir uptake, tissue volume, fractional anisotropy and mean diffusivity of the PSP population. Pearson's correlation coefficients were assessed across modalities on the regions identified by the sparse canonical correlation analyses. Sparse canonical correlation analyses identified associations between elevated flortaucipir uptake in the cerebellar dentate, red nucleus and subthalamic nucleus and decreased volume in the same regions, and decreased fractional anisotropy and increased mean diffusivity in tracts including the superior cerebellar peduncle, sagittal striatum and posterior corona radiata. Furthermore, decreased fractional anisotropy and increased mean diffusivity in the body of the corpus callosum and anterior and superior corona radiata were related to volume loss in the frontal lobe. Tau uptake measured by flortaucipir PET appears to be related to the neurodegenerative process of progressive supranuclear palsy, including reduced tissue volume and white matter tract degeneration.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  DTI; MRI; Multimodal imaging; PSP; Tau-PET

Mesh:

Year:  2019        PMID: 31279635      PMCID: PMC6779505          DOI: 10.1016/j.parkreldis.2019.07.001

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  31 in total

1.  Clinical correlates of white matter tract degeneration in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Ankit V Master; Ramesh Avula; Kejal Kantarci; Scott D Eggers; Heidi A Edmonson; Clifford R Jack; Keith A Josephs
Journal:  Arch Neurol       Date:  2011-06

Review 2.  Toward defining deep brain stimulation targets in MNI space: A subcortical atlas based on multimodal MRI, histology and structural connectivity.

Authors:  Siobhan Ewert; Philip Plettig; Ningfei Li; M Mallar Chakravarty; D Louis Collins; Todd M Herrington; Andrea A Kühn; Andreas Horn
Journal:  Neuroimage       Date:  2017-05-20       Impact factor: 6.556

3.  Track density imaging in progressive supranuclear palsy: A pilot study.

Authors:  Salvatore Nigro; Maria Giovanna Bianco; Gennarina Arabia; Maurizio Morelli; Rita Nisticò; Fabiana Novellino; Maria Salsone; Antonio Augimeri; Aldo Quattrone
Journal:  Hum Brain Mapp       Date:  2018-11-26       Impact factor: 5.038

4.  [18F]AV-1451 tau-PET uptake does correlate with quantitatively measured 4R-tau burden in autopsy-confirmed corticobasal degeneration.

Authors:  Keith A Josephs; Jennifer L Whitwell; Pawel Tacik; Joseph R Duffy; Matthew L Senjem; Nirubol Tosakulwong; Clifford R Jack; Val Lowe; Dennis W Dickson; Melissa E Murray
Journal:  Acta Neuropathol       Date:  2016-09-19       Impact factor: 17.088

5.  Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy--study in autopsy cases.

Authors:  I Aiba; Y Hashizume; M Yoshida; S Okuda; N Murakami; N Ujihira
Journal:  J Neurol Sci       Date:  1997-11-25       Impact factor: 3.181

6.  [18 F]AV-1451 tau positron emission tomography in progressive supranuclear palsy.

Authors:  Jennifer L Whitwell; Val J Lowe; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Christopher G Schwarz; Anthony J Spychalla; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  Mov Disord       Date:  2016-10-27       Impact factor: 10.338

7.  Modeling trajectories of regional volume loss in progressive supranuclear palsy.

Authors:  Keith A Josephs; Rong Xia; Jay Mandrekar; Jeffrey L Gunter; Matthew L Senjem; Clifford R Jack; Jennifer L Whitwell
Journal:  Mov Disord       Date:  2013-04-08       Impact factor: 10.338

8.  Relationship between neuronal loss and tangle formation in neurons and oligodendroglia in progressive supranuclear palsy.

Authors:  Chenghua Jin; Sadao Katayama; Masanori Hiji; Chigusa Watanabe; Koichi Noda; Shigenobu Nakamura; Masayasu Matsumoto
Journal:  Neuropathology       Date:  2006-02       Impact factor: 1.906

9.  Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria.

Authors:  Günter U Höglinger; Gesine Respondek; Maria Stamelou; Carolin Kurz; Keith A Josephs; Anthony E Lang; Brit Mollenhauer; Ulrich Müller; Christer Nilsson; Jennifer L Whitwell; Thomas Arzberger; Elisabet Englund; Ellen Gelpi; Armin Giese; David J Irwin; Wassilios G Meissner; Alexander Pantelyat; Alex Rajput; John C van Swieten; Claire Troakes; Angelo Antonini; Kailash P Bhatia; Yvette Bordelon; Yaroslau Compta; Jean-Christophe Corvol; Carlo Colosimo; Dennis W Dickson; Richard Dodel; Leslie Ferguson; Murray Grossman; Jan Kassubek; Florian Krismer; Johannes Levin; Stefan Lorenzl; Huw R Morris; Peter Nestor; Wolfgang H Oertel; Werner Poewe; Gil Rabinovici; James B Rowe; Gerard D Schellenberg; Klaus Seppi; Thilo van Eimeren; Gregor K Wenning; Adam L Boxer; Lawrence I Golbe; Irene Litvan
Journal:  Mov Disord       Date:  2017-05-03       Impact factor: 10.338

10.  Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy.

Authors:  Thomas E Cope; Timothy Rittman; Robin J Borchert; P Simon Jones; Deniz Vatansever; Kieren Allinson; Luca Passamonti; Patricia Vazquez Rodriguez; W Richard Bevan-Jones; John T O'Brien; James B Rowe
Journal:  Brain       Date:  2018-02-01       Impact factor: 13.501

View more
  8 in total

1.  The Legacy of the TTASAAN Report - Premature Conclusions and Forgotten Promises About SPECT Neuroimaging: A Review of Policy and Practice Part II.

Authors:  Dan G Pavel; Theodore A Henderson; Simon DeBruin; Philip F Cohen
Journal:  Front Neurol       Date:  2022-05-17       Impact factor: 4.086

2.  Histologic lesion type correlates of magnetic resonance imaging biomarkers in four-repeat tauopathies.

Authors:  Arenn F Carlos; Nirubol Tosakulwong; Stephen D Weigand; Marina Buciuc; Farwa Ali; Heather M Clark; Hugo Botha; Rene L Utianski; Mary M Machulda; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs; Jennifer L Whitwell
Journal:  Brain Commun       Date:  2022-04-28

Review 3.  Evolving concepts in progressive supranuclear palsy and other 4-repeat tauopathies.

Authors:  Maria Stamelou; Gesine Respondek; Nikolaos Giagkou; Jennifer L Whitwell; Gabor G Kovacs; Günter U Höglinger
Journal:  Nat Rev Neurol       Date:  2021-08-23       Impact factor: 42.937

4.  A technical review of canonical correlation analysis for neuroscience applications.

Authors:  Xiaowei Zhuang; Zhengshi Yang; Dietmar Cordes
Journal:  Hum Brain Mapp       Date:  2020-06-27       Impact factor: 5.038

5.  Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Hugo Botha; Farwa Ali; Heather M Clark; Joseph R Duffy; Rene L Utianski; Chase A Stevens; Stephen D Weigand; Christopher G Schwarz; Matthew L Senjem; Clifford R Jack; Val J Lowe; J Eric Ahlskog; Dennis W Dickson; Keith A Josephs
Journal:  Neuroimage Clin       Date:  2019-12-28       Impact factor: 4.881

6.  18F-AV1451 PET imaging and multimodal MRI changes in progressive supranuclear palsy.

Authors:  Nicolas Nicastro; Patricia Vazquez Rodriguez; Maura Malpetti; William Richard Bevan-Jones; P Simon Jones; Luca Passamonti; Franklin I Aigbirhio; John T O'Brien; James B Rowe
Journal:  J Neurol       Date:  2019-10-22       Impact factor: 4.849

7.  Neuroinflammation predicts disease progression in progressive supranuclear palsy.

Authors:  Maura Malpetti; Luca Passamonti; Peter Simon Jones; Duncan Street; Timothy Rittman; Timothy D Fryer; Young T Hong; Patricia Vàsquez Rodriguez; William Richard Bevan-Jones; Franklin I Aigbirhio; John Tiernan O'Brien; James Benedict Rowe
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-03-17       Impact factor: 13.654

8.  Integrated 18F-T807 Tau PET, Structural MRI, and Plasma Tau in Tauopathy Neurodegenerative Disorders.

Authors:  Cheng-Hsuan Li; Ta-Fu Chen; Ming-Jang Chiu; Ruoh-Fang Yen; Ming-Chieh Shih; Chin-Hsien Lin
Journal:  Front Aging Neurosci       Date:  2021-03-29       Impact factor: 5.750

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.